Metronidazole fenbufen capsules are a compound preparation containing two ingredients, metronidazole and fenbufen, and are generally used for a course of treatment in seven days. Metronidazole fenbuterol capsules are mainly used in clinical practice for gingivitis, periodontitis and other oral infections. Metronidazole is an anti-inflammatory drug with good efficacy against anaerobic bacterial infections. Fenbufen is a long-acting non-steroidal anti-inflammatory and analgesic drug, which can inhibit the activity of cyclooxygenase after entering the body through metabolism and reduce the synthesis of prostaglandins, producing anti-inflammatory, analgesic and antipyretic effects. The dose and duration of treatment should be strictly in accordance with the instructions or as prescribed by the physician. It should be noted that the most serious adverse effects of this drug are seizures and peripheral neuropathy at high doses, the latter mainly manifesting as numbness and abnormal sensation in the extremities, and in some cases persistent peripheral neuropathy can develop with long-term use. Patients should be aware that metronidazole fenbuterol capsules are contraindicated in pregnant and lactating women, as well as in children. Because the product rapidly passes through the placenta into the fetal circulation, animal studies have found intraperitoneal administration to be toxic to fetuses, whereas oral administration is not toxic. The effects of this product on the fetus have not been adequately and closely controlled and are therefore contraindicated in pregnant women.